Not entirely true. BUB's revenue for the HY period ended 31 December 2020 was $18M vs JAT's $13M. You are right that for same period, BUB incurred higher loss. I don't know what's the MC of both companies at that point but if you can provide me that information (and make sure you back it up with supporting screenshoot) then maybe I can explain to you why.
- Forums
- ASX - By Stock
- JAT
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-64
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.46M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 45.0¢ | $4.425K | 9.833K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 33334 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 0.450 |
1 | 50 | 0.425 |
3 | 22000 | 0.420 |
2 | 21300 | 0.410 |
4 | 40750 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 33334 | 1 |
0.550 | 51242 | 2 |
0.560 | 12073 | 3 |
0.590 | 20000 | 1 |
0.595 | 20000 | 1 |
Last trade - 15.40pm 12/11/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online